Moreover, after the Covid-s delta variant surged across the globe, several Johnson & Johnson vaccine receivers felt a sense of urgency. The propagated news about the vaccine efficacy on long-term has raised questions for J&J recipients. Consequently, the U.S. Food and Drug Administration is said to evaluate the efficacy of a second J&J shot later this month.
“Patients cannot wait for perfect data,” Dr. Leana Wen, an emergency physician and public health professor at George Washington University, tells CNBC Make It. “People who need additional protection now need to be given the option.”
Determining whether or not you need a Covid booster is “a complex decision that takes into account your medical history, your family circumstances and who you’re live with your Covid-19 exposures, as well as your risk tolerance,” Wen says.
“That is really what needs to happen in this case: Clinicians need to be able to exercise their judgment in order to recommend what is best for their patients,” Wen says.
